{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Losoxantrone",
  "nciThesaurus": {
    "casRegistry": "88303-60-0",
    "chebiId": "",
    "chemicalFormula": "C22H27N5O4",
    "definition": "An anthrapyrazole-based antineoplastic antibiotic. Losoxantrone intercalates into DNA, induces single- and double-stranded DNA breaks and inhibits topoisomerase II, thereby inhibiting DNA replication and repair as well as RNA and protein synthesis. Losoxantrone is less cardiotoxic than doxorubicin.",
    "fdaUniiCode": "47KPH00809",
    "identifier": "C1521",
    "preferredName": "Losoxantrone",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2107"
    ],
    "synonyms": [
      "Biantrazole",
      "CI-941",
      "DuP 941",
      "LOSOXANTRONE",
      "Losoxantrone",
      "losoxantrone"
    ]
  }
}